Floatz logo

Nabilone

Neuralgia

Eldon Loh, MDSmall moleculePhase 4 / ApprovedActive
BBB
72/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
72/ 100
Competitive Position
73/ 100

Competitive context

48 Active assets in the Neuralgia cohort.

Asset / SponsorPhaseRating
Dexmedetomidine
Universidad Juárez Autónoma de Tabasco
Phase 4BBB
Midazolam
Minia University
Phase 4BBB
Lidocaine
Ataturk University
Phase 4BBB
(±)-2-(O-Chlorophenyl)-2-(Methylamino)Cyclohexanone
Margaux M. Salas, PhD
Phase 4BBB
Marcaine
Medipol University
Phase 4BBB

View all 50 →

Same molecule, other indications

Nabilone is also rated in:

peripheral neuropathyDormant
BB
Indicative · Phase 4
68 / 100
View asset →
spinal cord injuryActive
BB
Indicative · Phase 3
64 / 100
View asset →
multiple sclerosisDormant
B
Indicative · Phase 4
61 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →